DrugPatentWatch Database Preview
Breckenridge Company Profile
» See Plans and Pricing
What is the competitive landscape for BRECKENRIDGE, and what generic and branded alternatives to BRECKENRIDGE drugs are available?
BRECKENRIDGE has forty approved drugs.
There are three tentative approvals on BRECKENRIDGE drugs.
Summary for Breckenridge
| US Patents: | 0 |
| Tradenames: | 38 |
| Ingredients: | 38 |
| NDAs: | 40 |
| Patent Litigation for Breckenridge: | See patent lawsuits for Breckenridge |
| PTAB Cases with Breckenridge as petitioner: | See PTAB cases with Breckenridge as petitioner |
Drugs and US Patents for Breckenridge
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breckenridge | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | SOLUTION;ORAL | 201466-002 | Nov 12, 2013 | AA | RX | No | No | Get Started for $10 | Get Started for $10 | ||||
| Breckenridge | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 212638-001 | Oct 9, 2019 | AP | RX | No | No | Get Started for $10 | Get Started for $10 | ||||
| Breckenridge | ENTECAVIR | entecavir | TABLET;ORAL | 208721-002 | Mar 15, 2018 | AB | RX | No | No | Get Started for $10 | Get Started for $10 | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for BRECKENRIDGE drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
